Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
KIDS · Nasdaq · United States · Surgical & Medical Instruments & Apparatus
In shortORTHOPEDIATRICS CORP is loss-making, burns cash and carries moderate debt, with revenue growing (+15.4% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -16.6% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -16.8% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -11.3% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -6.9% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 5.55× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.29× | 95/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -6.54× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.67 | 40/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -6.8% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 10.0% | 74/100 |
| Operating margin volatility | 1.6% | 94/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 24.6% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 98 | 122 | 149 | 205 | 236 |
| Cost of revenue | 25 | 32 | 37 | 56 | 64 |
| Gross profit | 73 | 91 | 111 | 149 | 173 |
| Research & development | 5.5 | 8.5 | 11 | 11 | 9.1 |
| Operating income | (18) | (25) | (27) | (35) | (39) |
| Interest expense | 0.1 | 2.4 | (0.2) | 2.6 | 6 |
| Pre-tax income | (17) | (3.7) | (21) | (42) | (39) |
| Income tax | (1.1) | (4.9) | (0.3) | (4.1) | 0.5 |
| Net income | (16) | 1.3 | (21) | (38) | (40) |
| Diluted EPS | −$0.84 | $0.06 | −$0.92 | −$1.64 | −$1.69 |
| Diluted shares (millions) | 19 | 21 | 23 | 23 | 23 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of ORTHOPEDIATRICS CORP are included in the Investor plan. Try free for 7 days →
2.67 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026